Vertraagde tijd
Hong Kong S.E.
04:11:06 16-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
5,13
HKD
|
+2,81%
|
|
+2,21%
|
+24,21%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
14.321
|
24.421
|
22.930
|
16.225
|
14.394
|
17.474
|
-
|
-
|
Bedrijfswaarde
1 |
14.321
|
24.421
|
22.930
|
16.225
|
14.394
|
17.474
|
17.474
|
17.474
|
K/w-verhouding
|
-
|
-
|
-
|
-
|
7,63
x
|
7,92
x
|
6,93
x
|
6,16
x
|
Dividendrendement
|
-
|
-
|
-
|
3,04%
|
6,36%
|
6,21%
|
5,81%
|
6,61%
|
Marktkapitalisatie/omzet
|
2,17
x
|
3,84
x
|
2,67
x
|
1,7
x
|
1,37
x
|
1,46
x
|
1,29
x
|
1,16
x
|
Bedrijfswaarde/omzet
|
2,17
x
|
3,84
x
|
2,67
x
|
1,7
x
|
1,37
x
|
1,46
x
|
1,29
x
|
1,16
x
|
Bedrijfswaarde/EBITDA
|
-
|
10.116.064
x
|
7.124.918
x
|
-
|
-
|
-
|
-
|
-
|
Bedrijfswaarde/FCF
|
-
|
-
|
14,9
x
|
13,3
x
|
-
|
9,29
x
|
12,2
x
|
8,87
x
|
FCF Yield
|
-
|
-
|
6,69%
|
7,5%
|
-
|
10,8%
|
8,2%
|
11,3%
|
Price to Book
|
-
|
-
|
1,71
x
|
1,14
x
|
0,94
x
|
1,09
x
|
1
x
|
0,91
x
|
Aantal aandelen (in duizenden)
|
3.377.571
|
3.549.571
|
3.549.571
|
3.527.141
|
3.519.271
|
3.501.810
|
-
|
-
|
Referentieprijs
2 |
4,240
|
6,880
|
6,460
|
4,600
|
4,090
|
4,990
|
4,990
|
4,990
|
Datum van publicatie
|
27-03-20
|
28-04-21
|
17-03-22
|
22-03-23
|
19-03-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
6.591
|
6.353
|
8.598
|
9.562
|
10.530
|
11.948
|
13.584
|
15.008
|
EBITDA
|
-
|
2.414
|
3.218
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
1.383
|
2.127
|
2.879
|
2.654
|
2.549
|
2.769
|
3.159
|
3.581
|
Operationele Marge
|
20,98%
|
33,48%
|
33,48%
|
27,76%
|
24,21%
|
23,18%
|
23,26%
|
23,86%
|
Resultaat voor belastingen (EBT)
1 |
-
|
-
|
-
|
-
|
2.344
|
2.709
|
3.091
|
3.506
|
Nettowinst (verlies)
1 |
-
|
-
|
-
|
-
|
1.880
|
2.229
|
2.540
|
2.880
|
Nettomarge
|
-
|
-
|
-
|
-
|
17,85%
|
18,66%
|
18,7%
|
19,19%
|
WPA
2 |
-
|
-
|
-
|
-
|
0,5360
|
0,6300
|
0,7200
|
0,8100
|
Free Cash Flow
1 |
-
|
-
|
1.534
|
1.216
|
-
|
1.881
|
1.433
|
1.970
|
FCF-marge
|
-
|
-
|
17,84%
|
12,72%
|
-
|
15,74%
|
10,55%
|
13,13%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
47,67%
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
84,39%
|
56,42%
|
68,4%
|
Dividend per aandeel
2 |
-
|
-
|
-
|
0,1400
|
0,2600
|
0,3100
|
0,2900
|
0,3300
|
Datum van publicatie
|
27-03-20
|
28-04-21
|
17-03-22
|
22-03-23
|
19-03-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
1.534
|
1.216
|
-
|
1.881
|
1.433
|
1.970
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
18,3%
|
19,5%
|
15,1%
|
12,8%
|
14%
|
14%
|
15%
|
ROA (netto-inkomsten/totale activa)
|
-
|
11,6%
|
12,6%
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
2 |
-
|
-
|
3,770
|
4,020
|
4,330
|
4,590
|
5,010
|
5,500
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
566
|
209
|
472
|
626
|
-
|
600
|
800
|
1.000
|
Capex/omzet
|
8,59%
|
3,29%
|
5,48%
|
6,55%
|
-
|
5,02%
|
5,89%
|
6,66%
|
Datum van publicatie
|
27-03-20
|
28-04-21
|
17-03-22
|
22-03-23
|
19-03-24
|
-
|
-
|
-
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +24,21% | 2,24 mld. | | +31,37% | 588 mld. | | -2,60% | 364 mld. | | +20,83% | 326 mld. | | +5,69% | 285 mld. | | +14,83% | 239 mld. | | +9,93% | 210 mld. | | -6,95% | 200 mld. | | +10,77% | 167 mld. | | +0,10% | 161 mld. |
Farmaceutische producten - Andere
|